The evaluation of early stage oxidative status in streptozotocin induced diabetes in rats

References

• Aebi, H., 1984. Catalase in vitro. Methods in enzymology, 105, 121–126.
   PubMed Web of Science ®Google Scholar
• Al-Malki, A.L., 2019. Potential impact of auxin in modulation of insulin resistance in diabetic rats. Archives of physiology and biochemistry, 1–5. doi:10.1080/13813455.2019.1661497
   PubMed Web of Science ®Google Scholar
• Baynes, J.W., 1991. Role of oxidative stress in development of complications in diabetes. Diabetes, 40 (4), 405–412.
   PubMed Web of Science ®Google Scholar
• Berkowitz, D.E., et al., 2003. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation, 108 (16), 2000–2006.
   PubMed Web of Science ®Google Scholar
• Board, E., et al., 1979. Treatment of EARLY DIABETES. Boston, MA: Springer US.
   Google Scholar
• Caldwell, R.W., et al., 2018. Arginase: a multifaceted enzyme important in health and disease. Physiological reviews, 98 (2), 641–665.
   PubMed Web of Science ®Google Scholar
• Ceriello, A., 1999. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes, nutrition & metabolism, 12 (1), 42–46.
   PubMedGoogle Scholar
• Cernea, S. and Dobreanu, M., 2013. Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochemia medica, 23 (3), 266–280.
   PubMed Web of Science ®Google Scholar
• Cho, N.H., et al., 2018. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, 138, 271–281.
   PubMed Web of Science ®Google Scholar
• Coskun, O., et al., 2005. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacological research, 51 (2), 117–123.
   PubMed Web of Science ®Google Scholar
• Daneman, D., 2006. Type 1 diabetes. The Lancet, 367 (9513), 847–858.
   PubMed Web of Science ®Google Scholar
• Dias, A.S., et al., 2005. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. The journal of nutrition, 135 (10), 2299–2304.
   PubMed Web of Science ®Google Scholar
• El-Bassossy, H.M., El-Fawal, R., and Fahmy, A., 2012. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascular pharmacology, 57 (5–6), 194–200.
   PubMed Web of Science ®Google Scholar
• ElGendy, A.A. and Abbas, A.M., 2014. Effects of warfarin and l-carnitine on hemostatic function and oxidative stress in streptozotocin-induced diabetic rats. Journal of physiology and biochemistry, 70 (2), 535–546.
   PubMed Web of Science ®Google Scholar
• Erisir, M., et al., 2012. Evaluation of optimal conditions for arginase activity in streptozotocin induced diabetic rats. Veterinární medicína, 50 (2), 69–76.
   Google Scholar
• Geyer, J.W. and Dabich, D., 1971. Rapid method for determination of arginase activity in tissue homogenates. Analytical biochemistry, 39 (2), 412–417.
   PubMed Web of Science ®Google Scholar
• Jang, Y.Y., et al., 2000. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacological research, 42 (4), 361–371.
   PubMed Web of Science ®Google Scholar
• Jin, L., et al., 2008. Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. European journal of pharmacology, 582 (1–3), 162–167.
   PubMed Web of Science ®Google Scholar
• Jorns, A., et al., 2005. Immune cell infiltration, cytokine expression, and -cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat. Diabetes, 54 (7), 2041–2052.
   PubMed Web of Science ®Google Scholar
• Kakkar, R., et al., 1997. Antioxidant defense system in diabetic kidney: a time course study. Life sciences, 60 (9), 667–679.
   PubMed Web of Science ®Google Scholar
• Kakkar, R., et al., 1998. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clinical science, 94 (6), 623–632.
   PubMed Web of Science ®Google Scholar
• Kövamees, O., Shemyakin, A., and Pernow, J., 2016. Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction. Diabetes and vascular disease research, 13 (5), 354–360.
   PubMed Web of Science ®Google Scholar
• Kröncke, K.-D., et al., 1995. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotozin contributes to islet cell DNA damage. Biological chemistry Hoppe-Seyler, 376 (3), 179–186.
   PubMed Web of Science ®Google Scholar
• Lally, F.J., Ratcliff, H., and Bone, A.J., 2001. Apoptosis and disease progression in the spontaneously diabetic BB/S rat. Diabetologia, 44 (3), 320–324.
   PubMed Web of Science ®Google Scholar
• Lowry, O., et al., 1951. Protein measurement with the Folin phenol reagent. The journal of biological chemistry, 193 (1), 265–275.
   PubMed Web of Science ®Google Scholar
• Maritim, A.C., Sanders, R.A., and Watkins, J.B., 2003a. Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. The journal of nutritional biochemistry, 14 (5), 288–294.
   PubMed Web of Science ®Google Scholar
• Maritim, A.C., Sanders, R.A., and Watkins, J.B., 2003b. Diabetes, oxidative stress, and antioxidants: a review. Journal of biochemical and molecular toxicology, 17 (1), 24–38.
   PubMed Web of Science ®Google Scholar
• McLean, P., Reid, E., and Gurney, M., 1964. Effect of azo-dye carcinogenesis on enzymes concerned with urea synthesis in rat liver. The biochemical journal, 91 (3), 464–473.
   PubMed Web of Science ®Google Scholar
• Miranda, K.M., Espey, M.G., and Wink, D.A., 2001. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide: biology and chemistry, 5 (1), 62–71.
   PubMed Web of Science ®Google Scholar
• Placer, Z.A., Cushman, L.L., and Johnson, B.C., 1966. Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Analytical biochemistry, 16 (2), 359–364.
   PubMed Web of Science ®Google Scholar
• Rees, D.A. and Alcolado, J.C., 2005. Animal models of diabetes mellitus. Diabetic medicine: a journal of the British diabetic association, 22 (4), 359–370.
   PubMed Web of Science ®Google Scholar
• Romero, M.J., et al., 2008. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circulation research, 102 (1), 95–102.
   PubMed Web of Science ®Google Scholar
• Sabry, M.M., et al., 2019. Interactive effects of apelin, renin-angiotensin system and nitric oxide in treatment of obesity-induced type 2 diabetes mellitus in male albino rats. Archives of physiology and biochemistry, 125 (3), 244–254.
   PubMed Web of Science ®Google Scholar
• Schnedl, W.J., et al., 1994. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes, 43 (11), 1326–1333.
   PubMed Web of Science ®Google Scholar
• Shosha, E., et al., 2020. Is the Arginase pathway a novel therapeutic avenue for diabetic retinopathy? Journal of clinical medicine, 9 (2), 425.
   Web of Science ®Google Scholar
• Stadler, K., et al., 2003. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free radical biology & medicine, 35 (10), 1240–1251.
   PubMed Web of Science ®Google Scholar
• Szkudelski, T., 2001. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological research., 50 (6), 537–546.
   PubMed Web of Science ®Google Scholar
• Thangaraju, P., et al., 2014. Dual blockade of renin angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model. North American journal of medical sciences, 6 (12), 625.
   PubMedGoogle Scholar
• Tolman, K.G., et al., 2007. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes care, 30 (3), 734–743.
   PubMed Web of Science ®Google Scholar
• Wohaieb, S.A. and Godin, D.V., 1987. Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. effects of insulin treatment. Diabetes, 36 (9), 1014–1018.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., et al., 2003. Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes. Journal of cardiovascular pharmacology, 42 (2), 191–196.
   PubMed Web of Science ®Google Scholar